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[57] ABSTRACT 
A virus having the identifying characteristics of ATCC 
VR2396 is disclosed. This virus has the trait of enhanced 
polyhedra production stability and resists forming a few 
polyhedra mutant virus. A method of protecting crops from 
insects comprising applying an insecticidally effective 
amount of virus having the identifying characteristics of 
ATCC VR2396 is also disclosed. 
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2 
fewer polyhedra (FP mutants). 
For gypsy moth virus production to be competItIVe, 
means of reducing production costs must be devised. One 
approach is the development of insect cell lines that produce 
5 high amounts of polyhedra. Lynn et al., (Appl. Envron. 
Microbiol., 55, 1049-1051, 1989) have developed a fat-
body cell line that produces greater amounts of polyhedra 
than other gypsy moth cell lines. 
This application is a divisional of U.S. Ser. No. 08/290, 
634, filed Aug. 15, 1994, now U.S. Pat. No. 5,420,031, 
which is a continuation of U.S. Ser. No. 08/015,961, filed 
Feb. 8, 1993, now abandoned. 
FIELD OF THE INVENTION 
What is needed in the art of gypsy moth control is an 
10 improved strain of LdNPV capable of enhanced production. 
The general field of the present invention is methods of SUMMARY OF THE INVENTION 
controlling plant pests, such as gypsy moths. Specifically, The present invention is a virus having the identifying 
the field of the present invention is gypsy moth virus strains. 15 characteristics of ATCC VR2396. This virus has the trait of 
enhanced resistant to mutation to an FP form of LdNPV 
BACKGROUND virus. 
Chemical pesticides and fungicides are the most com-
monly used control agents for forest insect pests and fungal 
diseases. In excess of 350 billion pounds of these agents are 
used annually in the United States to control pests and 
diseases in forestry, agriculture, and residential areas. Broad 
spectrum insecticides and fungicides have adverse impacts 
The present invention is also a virus derived from ATCC 
VR2396, wherein the virus retains the characteristics of 
20 polyhedra production stability. 
The present invention is also a method of protecting 
plants from insects, comprising applying to an insect or an 
insect habitat an insecticidally effective amount of a virus 
having the identifying characteristics of ATCC VR2396. In 
a preferred form of the invention, the insects are gypsy 
moths. 
not only on their target organisms but also on beneficial 
insects and fungi and, consequently, on the entire ecosystem. 25 
In addition, chemical residues may cause health problems 
among the human population. The present invention is also an insecticidal composition 
comprising an insecticidal amount of a virus having the 
30 identifying characteristics of ATCC VR2396 and an inert 
carrier. 
Interest in biological insect and fungal control agents is 
growing as a consequence of concerns regarding chemical 
pesticide use. A number of bacteria synthesize antifungal 
compounds and over 1500 microorganism and microbial 
products have been identified that are insecticidal. Gener-
ally, natural control agents have little adverse ecological 
impact due to their specificity for the target host. Long term 
environmental hazards and health concerns are not a factor 
with biological control agents because chemical residues are 
It is an object of the present invention to control insect 
pests. 
It is another object of the present invention to provide an 
35 LdNPV virus with enhanced polyhedra production stability. 
not present. Unfortunately, biological control agents suffer 
from several disadvantages in comparison to chemical pes-
ticides, including cost of production, efficacy, and stability. 40 
One particularly troublesome plant pest is the gypsy moth 
Lymantria dispar. The gypsy moth was first imported from 
Europe into North America near Boston in 1869. Since then, 
the area of gypsy moth infestation has increased to include 
almost the entire New England area, New York, Delaware, 45 
Maryland, New Jersey, Pennsylvania, Virginia, West Vir-
ginia, Ohio, and Michigan. (McFadden, et al., Forest Insect 
Guilds: Patterns of Interaction with Host Trees, Y. N. 
Baranchikov, et al. pp. 172-186. US Department of Agri-
culture, For. Servo Gen. Tech. Rep. NE-1S3, Radnor, Pa., 50 
1989.) Several chemical insecticides have been used for 
gypsy moth control. DDT is one of the most effective 
chemical insecticides used against gypsy moths. 
Knowledge of the environmental impacts of DDT and 
other chemical insecticides has caused all industry shift to 55 
the use of agents such as Dimilin and Bacillus thuringiensis 
(Bt) for gypsy moth control. The Lymantria dispar nuclear 
polyhedrosis virus (LdNPV), which is pathogenic to Lyman-
tria dispar (gypsy moth), is also used as a biocontrol agent. 
LdNPV has the significant advantage over other control 60 
agents of specificity for the gypsy moth. Consequently, 
LdNPV is the agent of choice for all areas and particularly 
for use in environmentally sensitive areas. However, LdNPV 
is not used extensively for gypsy moth control because of 
high production costs and low efficacy. One particular 65 
problem with LdNPV propagation in cell culture is the 
propensity of the virus to mutate into a form that produces 
It is another object of the present invention to provide an 
LdNPV virus with enhanced resistance to mutating to an FP 
form of LdNPV virus. 
It is an advantage of the present invention that insect 
control may be provided at lower cost. 
It is another advantage of the present invention that ATCC 
VR2396 may be propagated with a fewer amount of FP 
mutants forming. 
Other objects, advantages and features of the present 
invention will become apparent after review of the specifi-
cation, drawings and claims. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. IA is a graphical comparison of the amount of 
pol yhedra produced in cells infected with A21-MPV after 14 
serial passages versus cells infected with A21-2 after 6 serial 
passages in L. dispar 652Y cells; FIG. IB is a tabular form 
of the same data. 
FIG. 2A is a graphical comparison of the number of cells 
found to contain polyhedra after infection with A21-MPV 
after 14 serial passages versus the number of cells found to 
contain polyhedra after infection with A21-2 after 6 serial 
passages in L. dispar 652Y cells; FIG. 2B is a tabular form 
of the same data. 
FIG. 3A is a graphical comparison of the amount of 
budded virus produced by isolates A21-MPV after 14 serial 
passages and A21-2 after 6 serial passages in L. dis par cells; 
FIG. 3B is a tabular form of the same data. 
FIG. 4A demonstrates the retention of wild-type pheno-
type by A21-MPV through multiple passages; FIG. 4B 
5,462,732 
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demonstrates the percentage of cells with polyhedra after 
infection with A21-MPV during extended serial passage in 
L. dispar 652Y cells. 
4 
and release nucleocapsids which infect the insect midgut 
cells, thereby initiating the infection process. 
For commercial applications, LdNPV is currently pro-
duced in gypsy moth larvae at a cost of approximately FIG. SA is a graphical comparison of polyhedra per cell 
of cells infected with A21-MPV and cells infected with A21 
during serial passage; FIG. SB is a tabular form of the same 
data. 
5 $30.00 for enough polyhedra to treat an acre of forest. 
Production is the most expensive component in the com-
mercial use of LdNPV. Virus production is limited by the 
efficiency of production of polyhedra in larvae. Efforts to 
produce polyhedra in cell culture systems are being made to FIG. 6A is a graphical comparison of the percentage of 
polyhedra in cells infected with A21-MPV versus A21 
during serial passage; FIG. 6B is a tabular form of the same 
data. 
10 generate a more economical production methodology. In 
comparison, production costs of Dimilin and Bt are approxi-
mately $3.00 per acre equivalent. 
FIG. 7A is a graphical comparison of budded virus 
produced by isolates A21 and A21-MPV during serial pas-
sage in L. dis par 652Y cells; FIG. 7B is a tabular form of the 15 
same data. 
FIG. 8 indicates the percentage of A21 plaques exhibiting 
the FP phenotype compared to the number of A21-MPV 
plaques exhibiting the FP phenotype during serial passages. 
However, problems exist in obtaining virus from cell 
culture. A class of mutant baculoviruses called few polyhe-
dra (FP) mutants are generated at high frequency during 
viral replication in insect cell culture. FP mutants have the 
characteristics of producing few polyhedra that contain few 
or no viral nucleocapsids and are noninfectious. In addition, 
FP mutants produce a greater amount of budded virus 
20 (non-occluded virus) compared to wild type virus. 
DESCRIPTION OF THE INVENTION 
I. Brief Overview 
FP mutants have been generated during serial passage of 
the Autographa californica nuclear polyhdrosis virus (AcM-
NPV), Trichoplusia pi MNPV (TnMNPV), Galleria mel-
lonella MNPV (GmMNPV), and Lymantria dispar MNPY. 
25 Studies on AcMNPV have shown that FP mutants are often We have identified an LdNPV isolate, derived from 
LdNPV isolate A21, that exhibits an enhanced stability of 
wildtype polyhedra production levels during passage in L. 
dispar 652Y cells. All wild-type LdNPV isolates studied to 
date rapidly mutate during serial passage in 652Y cells to 
few polyhedra (FP) viral mutants. FP mutants exhibit the 30 
characteristics of production of an average of 4-10 polyhe-
dra per cell, of polyhedra that are virtually devoid of viral 
nucleocapsids, and of a greater amount of budded virus 
compared to wild-type virus. In contrast, wild-type virus 
produce an average of 30--60 polyhedra per cell that contain 35 
many viral nucleocapsids and a lower amount of budded 
virus compared to FP mutants. 
generated through the insertion of host DNA sequences into 
the viral genome. The frequency of FP mutant genesis 
during viral serial passage is specific to the virus species 
being passed. Table I below summarizes the frequency ofFP 
mutant formation as a function of serial passage. 
Virus 
TABLE I 
Passages Necessary to Accumulate FP 
Mutant Percentages of: 
25% 50% 75% >90% 
40 
The unique attribute of our new isolate, A21-MPV, is a 
reduced tendency to mutate to an FP mutant during serial 
passage. Consequently, during production of LdNPV poly-
hedra, which requires serial passage, isolate A21-MPV will 
produce a far greater number of polyhedra than wildtype 
virus. In addition, a greater percentage of 652Y cells 
infected with isolate A21-MPV produce polyhedra in com-
parison to the percentage of cells that produce polyhedra 45 
after infection with wild-type LdNPY. 
GrnNMPV' 4.5 5.5 7.0 8.0 
TnMNPVb 4.0 5.0 6.0 10.0 
AcMNPVc 1.0 1.5 3.5 >4.0 
LdMNPVd 1.0 2.0 
a. Fraser, et al., (1982) VIrology, 117,366-378. 
b. Potter, et al., (1976) J. Virology, 18, 1040-1050. 
c. Hink, et al., (1976) J. Invertebrate Pathology, 27, 49-55. 
d. Slavicek, J. M. Unpublished data 
Our approach to increase polyhedra production in cell 
culture is the development of a viral strain that exhibits a low 
frequency of FP mutant generation and consistently pro-
duces polyhedra without reductions as a consequence of 2. In General 
Two forms of LdNPV (occluded and non-occluded virus) 
are produced during viral replication. (Granados, et al., The 
Biology of Baculoviruses, R. R. Granados and B. A. Federici 
(eds.) pp. 89-108. CRC Press, Boca Raton, Fla., 1986.) 
Early after viral infection, non-occluded virus is produced. 
This virus leaves the cell and is responsible for secondary 
infections within the hemocoel of the host insect. A different 
form of virus is produced late in infection that is occluded 
into a protein matrix composed primarily of a viral-encoded 
protein. These structures, approximately I to 3 micrometers 
in diameter and polyhedral in shape, are termed "polyhedral 
occlusion bodies" or "polyhedra". Nucleocapsids within 
polyhedra are protected from most environmental conditions 
with the exception of ultraviolet light. 
Gypsy moth virus is applied through sprayers in the field 
in the form of polyhedra, which are ingested by gypsy moth 
larvae feeding on tree foliage. Once within the alkaline 
environment of the insect midgut, the polyhedra dissolve 
50 passage. These traits are what we mean by "polyhedra 
production stability". 
Our preliminary studies with LdNPV polyhedra produc-
tion in 652Y cells found a reduction in the number of 
polyhedra produced as a function of virus passage number. 
55 When non-occluded virus is obtained from fourth-instar 
gypsy moth larvae (that were infected per os with polyhedra) 
and used to infect 652Y cells, the infected cells produce 
approximately 50 polyhedra per cell (Table 2). After five 
passages in cell culture, the number of polyhedra produced 
60 per cell decreased to approximately 6. The cost of cell 
culture production could be reduced if the initial high level 
of polyhedra formation could be stabilized. 
We have identified a viral variant (termed A21-MPV, 
which stands for Many Polyhedra Variant) that maintains a 
65 high level of polyhedra synthesis after repeated passage in 
cell culture (Table 2). 652Y cells infected with MPV contain 
approximately 45 polyhedra per cell. In addition, more of 
5,462,732 
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the infected cells produce polyhedra in comparison to wild 
type isolate A21. Virus A21-MPV has been deposited with 
the American Type Culture Collection, Rockville, Md., on 
Dec. 16, 1992 at Accession Number VR2396 under the 
conditions of the Budapest Treaty. Deposit of this sample 5 
does not imply or grant a license to use the virus. 
TABLE 2 
Polyhedra 
10 1st passage production per Percentage of 
polyhedra cell after more cells containing 
Isolate production than 5 passages polyhedra 
A21 52 6 51 
A21·MPV 58 45 85 
15 
3. A21-MPV Isolation 
6 
infected with isolate A21, due to the large number of 
polyhedra present. The majority of infected cells, greater 
than 99.99%, contained from 4 to 10 polyhedra, which is 
characteristic of FP viral mutants. The virus that infected the 
cells containing a large number of polyhedra was purified 
and termed LdNPV isolate A21-MPV (many polyhedra 
variant, MPV). Isolate A21-MPV was serially passed in cell 
culture for 20 passages. The number of 652Y cells used for 
each passage were 1x104, 1x105, 1x106 , and 5x106 for 
passages 1-8,9-10, 11 and 12-20, respectively. 
To generate cell culture lines of LdNPV isolates A21, 
B21, 163, and 122, budded virus was obtained from L. 
dispar larvae infected with these isolates and used to infect 
652Y cells in culture. Budded virus from these initial 
infections was used to generate the plaque purified viral 
lines A21-2, B21-1, 122-2, and 163-2. After plaque purifi-
cation the isolates were serially passed in cell culture for 6 
passages. The number of 652Y cells infected at each passage 
were 1x104, 1x105, lx106, and 5x106 for passages 1, 2, 3 LdNPV isolates A21, B21, 122, and 163 were purified to 
genotypic homogeneity by low dose infection of L. dispar 
larvae. Fourth instar larvae were fed diet containing a dose 
20 and 4-6, respectively. 
of LdNPV that caused approximately 4 to 10% mortality. 
Polyhedra were collected from individual cadavers, and 
used for a second round of low dose infections. Polyhedra 
were collected from individual cadavers, viral genomic 25 
DNA was isolated and analyzed to assess the degree of 
genotypic heterogeneity present. Isolates A21, B21,163 and 
122 appeared to be genotypically homogenous and were 
used for further investigations. 
The initial purpose of the experiment during which we 30 
isolated A21-MPV was to develop the methodology for 
generation of recombinant viruses. LdMNPV isolate A21 
and a transplacement plasmid pLd-B-Gal that contains the 
beta galactosidase gene from E. coli were examined in this 35 
study. 
Lymantna dispar 652Y cells were propagated in a modi-
fied insect cell culture medium, such as "GOODWIN'S 
IPL-52B" (JRH Biosciences) medium with 10% heat-inac-
tivated fetal bovine serum and 6.25 roM glutamine. 2x105 40 
cells were plated per well in P6 plates (Coming) prior to 
transfection. Media was removed and replaced with 1.5 ml 
serum free media, and 100 ul of lipofection solution (50 ul 
10 roM Tris, 1 roM EDTA, pH 7.5; 2 ug, 5 ug, and 10 ug of 
LdMNPV DNA, and 4 ug, 2 ug, and 4 ug of pLd-B-Gal 45 
DNA for trials A, B, and C, respectively; and 50 ul of a 
transfection reagent, such as "LIPOFECTIN" reagent, 
Gibco BRL) was added to the P6 wells. After a 4 hour 
incubation period the media was replaced with complete 
media containing 50 ug/ml gentamicin. Fifteen days after 50 
transfection the cells were harvested and used for enzymatic 
B-galactosidase assays to detect the presence of recombinant 
LdMNPV containing the B-galactosidase gene. The percent-
age of recombinant virus present was calculated after deter-
mination of recombinant virus titer by plaque assay (using 55 
agarose containing a substrate for the enzyme ~-galaxctosi­
dase, such as "BLDO GAL" supplied by Gibco) and the total 
virus titer by TCID-50 Assay. 
LdMNPV isolate A21-MPV was identified in this study. 
However, A21-MPV does not contain the beta-galactosidase 60 
gene. Isolate A21-MPV is a mutant derivative of isolate A21 
that was detected during the course of the study described 
above. The genesis of A21-MPV is not related to the 
experimental manipulations used to generate a recombinant 
virus. Cells containing isolate A21-MPV were recognized 65 
through examination of infected cells by light microscopy. 
These cells were black in color, in contrast to all other cells 
4. Restriction endonuclease analysis of isolate 
A21-MPV. 
A21 and A21-MPV genomes were subject to restriction 
endonuclease digestion with BglII, EcoRI, EcoRV, HindIII, 
BarnHI, and PstI, and the digestion profiles were compared 
to determine whether DNA restriction fragment length poly-
morphisms existed between the viruses. No differences in 
DNA fragment lengths were detected. This finding supports 
the hypothesis that isolate A21-MPV is a mutant derivative 
of isolate A21. The approach used in this comparison will 
detect DNA insertions or deletions of approximately 0.5 kb 
or greater in length, and nucleotide additions, deletions or 
alterations of the restriction endonuclease recognition sites 
of the enzymes used. 
5. Bioassay data on isolate A21-MPV, A21, and 
Gypchek (a standard gypsy moth virus). 
Comparative bioassays were performed as described in 
Slavicek et al., (1992, 1. Invertebrate Pathology 59: 
142-148). Briefly, polyhedra pastes of the various isolates 
were suspended in 10 ml of Sterile 0.05M Tris-HCI buffer, 
pH 7.2, and briefly sonicated to disperse the polyhedra. A 
100-mg lyophilized sample of standard gypsy moth virus, 
such as Gypchek, was similarly suspended and vigorously 
ground in a glass tissue homogenizer for 3 min. Five serial 
lO-fold dilutions of each of the stock virus suspensions were 
prepared in Tris buffer. Dilutions were prepared such that 
final polyhedra concentrations in diet fed to test insects 
ranged between 1x102 and 1x107/ml. One milliliter of 
dilution was added to 99 ml of tempered (520 C.) diet and 
vigorously mixed with a variable-speed stirrer (5000 rpm) 
for 30 sec. Virus-treated diet was cooled and cooled and cut 
into 1.25-cm3 cubes. 
Each virus dosage was presented to five groups of 10 
newly molted second instar larvae from a standard labora-
tory strain of the gypsy moth (New Jersey, F34). Each group 
of 10 larvae was confined to a 100x15-mm plastic petri dish 
and given two 1.25-cm3 virus-treated diet cubes on which to 
feed for 48 hr. Larvae were given untreated diet ad libitum 
for the remaining 12 days of the bioassay. Five groups of 10 
larvae (controls) were fed untreated diet for 14 days. Larvae 
were reared in a growth chamber at 24±2° under a 16/8-hr 
light/dark photoperiod and observed daily for mortality. 
Dead larvae were removed and examined microscopically to 
5,462,732 
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confirm MPV deaths. 
Mortality data were examined by Probit analysis using a 
statistical software program, such as "POLO-PC" (LeOra 
Software, Berkeley, Calif.). Potencies of isolates A2I-MPV 
and A21 relative to standard Gypchek were estimated by 5 
comparing LCso values. 
Gypchek is the name of the LdMNPV registered by the 
Forest Service and is used currently for gypsy moth control. 
Gypchek is available from U.S. Forest Service, Northeastern 
Forest Experiment Station, Hamden, Conn. 10 
The results of the bioassay are tabulated in Table 3. 
TABLE 3 
Isolate LC-50" Limitsb LC-90" Limits 15 
Gypchek 3800 2500-6000 24,000 14,000-56,000 
A2l 4700 2800-7800 32,000 17,000-82,000 
A2l-MPV 5000 3400-7600 39,000 23,000-86,000 
". LC-50 and LC-90 (lethal concentration) values are the number of polyhedra 20 
fer ~. of diet that cause 50% and 90% larval mortality, respectively . 
. Llllut values are numbers of polyhedra per ml of diet that cause 50% and 
90% larvae mortality, respectively. 
The minor differences found in LC-50 and LC-90 values 
exhibited by isolates A2I, A2I-MPV and Gypchek were not 
significant. This finding indicates that the biological activity 
of A21-MPV is essentially the same as Gypchek, and 
consequently A2I-MPV could be used for control of the 
gypsy moth. 
6. Microscopy Comparison 
25 
30 
Comparison of L. dispar 652Y cells infected with LdM-
NPV isolates A21-2 and A21-MPV via light microscopy 
demonstrates the difference in polyhedra production and, 35 
thus, the biological difference between the two viruses. 
652Y cells were infected with 0.2 TCID-50 units per cell of 
A21-2 and A2I-MPY. Seven days after infection the cells 
were examined by light microscopy and photographed at 
lOOX magnification. The cells infected with isolate A21-2 40 
contain very few polyhedra. In contrast, cells infected with 
A2I-MPV contain a large number of polyhedra and appear 
black at this magnification level. 
8 
propylene oxide. 
The samples were infiltrated over a 24-hr period with 
propylene oxide: "PolylBed 812" (25.55 g "Poly Bed", 13.5 
g dodecenylsuccinic anhydride, 10.9 g nadic methylanhy-
dride, Polysciences) at 2:1, 1:1, and 1:2 ratios. After infil-
tration, the polyethylene capsules were flushed with freon 
and filled with plastic embedding medium, such as "POLY! 
BED 812 containing 2% DMP 30 (Polysciences), incubated 
at 35° C. for approximately 15 hr, 45° C. for 8 hr and finally 
at 60° C. overnight. The samples were sectioned with a 
microtonme, such as a diamond knife on a Reichert-]ung 
"ULTRACUT E43", the sections stained for 20 min in 5% 
uranyl acetate in methanol, poststained in lead nitrate (2.7% 
lead citrate, 3.5% sodium citrate, 0.I6N NaOH), and viewed 
with a Hitachi model HU l1E-I transmission electron 
microscope. Polyhedra cross sections were photographed, 
and the number of virions present within cross-sections were 
quantified by counting. 
In the A21 samples, numerous viral nucleocapsids are 
evident in cross-sections produced at the first passage. In 
contrast, cross-sections of polyhedra produced at the fifth 
passage contain few or no viral nucleocapsids. In the A2I-
MPV sample, numerous viral nucleocapsids are evident in 
cross-sections produced at both the first passage and fifth 
passage. The presence of numerous viral nucleocapsids in 
polyhedra produced at the fifth passage by A21-MPV indi-
cates that this isolate is producing normal polyhedra at this 
passage, in contrast to isolate A21. 
7. Comparison of Polyhedra Production Attributes 
of Isolates A2I-MPV and A21-2 After Plaque 
Purification in Cell Culture 
The number of polyhedra produced per cell within cells 
containing polyhedra, the percentage of cells with polyhe-
dra, and the amount of budded virus produced by isolates 
A2I-MPV after 14 passages in cell culture and isolateA21-2 
after 6 passages in cell culture were determined and com-
pared. The number of polyhedra per cell produced by 
isolates A2I-MPV and A21-2 was determined 3, 5, and 7 
days post infection (p.i.). On all days p.i. examined, cells 
infected with isolate A2I-MPV contained significantly more 
polyhedra per cell within cells containing polyhedra com-
pared to cells infected with isolate A21-2 (FIG. 1). At seven 
days p.i. cells infected withA2I-MPV contained an average 
of 46.4 polyhedra, in contrast to 5.2 polyhedra per cell in 
cells infected with A21-2. 
The percentage of cells containing polyhedra was deter-
Electron micrographs of polyhedra cross-sections pro-
duced by isolate A21 and A2I-MPV infection at passage 1 45 
and passage 5 can also differentiate between the two strains. 
652Y cells were infected with 0.2 TCID-50 units per cell of 
either A21 or A2I-MPV. Seven days after infection polyhe-
dra were harvested and prepared for examination by electron 
microscopy. 50 mined 3, 5, and 7 days p.i. A significantly greater percentage 
of cells were found to contain polyhedra at 3, 5, infected 
with A21-2 (FIG. 2). At 7 days p.i. an average of 85.7% of 
cells infected with A2I-MPV contained polyhedra. In con-
trast, 64.3% of cells infected with A21-2 contained polyhe-
To prepare for electron microscopy, polyhedra were fixed 
in sodium cacodylate buffer, pH 7.2 (0.05M sodium cacody-
late, 0.5 mM HCI), containing 1 % glutaraldehyde at 4° C. 
for 20 min. Polyhedra were then fixed in sodium cacodylate 
buffer with 3% glutaraldehyde for 1 hr at 4° C. The samples 55 
were washed 3X in sodium cacodylate buffer over a I-hr 
period. The samples were postfixed in sodium cacodylate 
buffer containing 2% osmium tetroxide for 2.5 hr at ambient 
temperature and then washed 3X in sodium cacodylate 
buffer over a I-hr period. Molten agar was added to the 60 
samples (final concentration 2%) and allowed to gel. The 
samples then were cut into I_mm2 blocks and incubated 
overnight in 35% ethanol. The samples were dehydrated 
through incubation in an ethanol series (35, 50, and 70% 
with 2% uranyl acetate, 85, 95, IOO%-3X) for 5-7 min at 65 
each step, except for the 70% step which was for 1 hr. The 
samples were then washed 3X (10 min each wash) in 
dra 7 days p.i. 
The amount of budded virus produced by isolates A21-
MPV and A21-2 was determined 1,3,5, and 7 days p.i. On 
days 3, 5, and 7 p.i., A21-2 produced a greater amount of 
budded virus in comparison to A2I-MPV (FIG. 3). On days 
5 and 7 p.i. A21-2 produced significantly more budded virus 
than A2I-MPV. 
These results demonstrate that isolate A2I-2 exhibits the 
attributes of an FP mutant at the 6th passage in cell culture. 
In contrast, A2I-MPV has retained a wild-type polyhedra 
production phenotype through the 14th serial passage. A2I-
MPV was then serially passed an additional 6 times through 
passage 20. As shown in FIG. 4, A21-MPV retained a 
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wild-type phenotype through the 20th passage. These results 
demonstrate the enhanced stability of polyhedra production 
exhibited by A21-MPV. 
10 
fewer polyhedra in comparison to the previous passage. In 
contrast, no significant difference was found in the number 
of polyhedra per cell after infection with A21-MPV during 
five serial passages. 
At the first passage, cells infected with A21-MPV and 
A21 exhibited the same percentage of cells containing 
polyhedra. At passages two through five a significantly 
greater percentage of cells infected with A21-MPV con-
tained polyhedra in comparison to cells infected with A21. 
Isolates B21-1, 122-2 and 163-2 were serially passed in 
652Y cells for 6 passages as described for isolate A21-2. 5 
Similarly to A21-2 isolates B2l-1, 122-2, and 163-2 exhib-
ited the attributes of FP mutants at the 6th passage. This 
result demonstrates the high frequency of FP mutants at the 
6th passage and demonstrates the high frequency of FP 
mutant formation with wild-type strains of LdNPV in con-
trast to isolate A21-MPV 
10 At passage five, 84.0% of cells infected with A2l-MPV 
contained polyhedra whereas only 51.2% of cells infected 
with A21 contained polyhedra. In addition, A21-MPV 
exhibited a significant increase in the percentage of cells 
containing polyhedra after the first passage. In contrast, A21 
8. Polyhedra Production Characteristics During 
Serial Passage 
To further determine the stability of polyhedra production 
by A21-MPV and determine the number of passages nec-
essary for a wild-type virus to mutate to an FP mutant, 
polyhedra production by isolates A21 and A21-MPV were 
examined through five passages in cell culture. Viral nucleo-
capsid occlusion characteristics of A21 and A21-MPV dur-
ing serial passage are related below in Table 4. LdMNPV 
isolates A21 and A21-MPV were serially passed five times 
15 exhibited a significant reduction in the percentage of cells 
containing polyhedra after the first passage. FIG. 6 graphi-
cally displays these results. 
in L. dispar 652Y. L. dispar larvae were infected per os with 
A21 (non-plaque purified) polyhedra produced in larvae and 
A21-MPV polyhedra produced in cell culture. Five days 
after infection larvae were bled, and the hemolymph was 
used to infect 1x1Q6 L. dispar 652Y cells at 0.2 TCID/50 
units per cell. This first infection in cell culture was passage 
number 1. Budded virus from this infection was then used to 30 
infect new cells to generate passage 2. The remaining 
passages examined in this study, passages 3-5, were gener-
ated using budded virus from the previous passage as 
inoculum. 
Isolate A21-MPV exhibited stable budded virus produc-
tion during five serial passages. The amount of budded virus 
20 produced by A21-MPV was less than the amount of budded 
virus produced by A21 at passages 2-5. This difference was 
found to be significant at passages 2, 4, and 5, and nearly 
significant at passage 3. In addition, A21 exhibited an 
increase in budded virus production after the first passage. 
25 FIG. 7 graphically displays these results. 
Polyhedra produced by these isolates after each passage 35 
were prepared for examination by electron microscopy as 
described above. The number of viral nucleocapsids present 
in polyhedra cross sections were determined, and are pre-
sented below in terms of the number of nucleocapsids 
present per square micrometer of cross section surface area 40 
(Table 4). 
TABLE 4 
The percentage of A21-MPV and A21 viruses exhibiting 
the FP or MP phenotype was determined during serial 
passage. Budded virus produced at each serial passage was 
used to generate viral plaques. Ninety-six plaques of each 
isolate after each passage were used to infect L. dispar 652Y 
cells, and the infections were scored as exhibiting either the 
MP or FP phenotype. Budded virus obtained from insect 
hemolymph was used for passage zero for both viral isolates. 
As shown in FIG. 8, the percentage of A21 plaques exhib-
iting the FP phenotype rapidly increased during serial pas-
sage from zero to 82% after just two serial passages. In 
contrast, A21-MPV maintained the MP phenotype during 
cell passage. 
9. Viral formulation and application for gypsy moth 
control 
We envision that the A21-MPV isolate may be applied to 
Number of viral nucleocapsids per urn2 of cross section area 
Passage Passage Passage Passage Passage 
Isolate I 2 3 4 5 
A21 5.7 4.0 2.5 1.1 0.5 
A21-MPV 5.2 2.9 5.7 6.1 3.1 
45 insects or insect habitats in a manner similar as that currently 
used for LdMNPV The virus must be ingested by the insect 
to be effective. However, insects may also become infected 
as a consequence of ingestion of virus present on the insect 
or on insect egg masses. Therefore, in the case of plants, the 
virus will typically be applied to leaf surfaces. 50 
The number of viral nucleocapsids present in polyhedra 
produced by A21 decreased during serial passage from an 
average of 5.7 at passage 1 to 0.5 at passage 5. In contrast, 
the number of nucleocapsids present in polyhedra produced 55 
by isolate A21-MPV remained essentially constant during 
five serial passages. 
L. dispar 652Y cells exhibited essentially the same num-
ber of polyhedra per cell at the first passage infection with 
isolates A21-MPV andA21 (FIG. 5). In contrast, at passages 60 
two through five, cells infected with A21-MPV contained 
significantly more polyhedra per cell compared to cells 
infected with A21 (FIG. 5). After five serial passages, cells 
infected with A21-MPV contained an average of 35.4 poly-
hedra. In contrast, cells infected with A21 contained an 65 
average of only 6.4 polyhedra per cell. After each serial 
passage, cells infected with A21 contained significantly 
LdMNPV has been formulated as described below for 
gypsy moth control: 
10 g Gypchek (5.0xlQlO polyhedra per gram) 
227 g (6% wtlvol) a UV light screen, such as "ORZAN 
LS" ITT Raynonier, Seattle, Wash.) 
0.47 liters (12.5% by vol) a liquid supplement consisting 
offeed stock molasses, such as "PRO MO", (Southern 
States Cooperative, Richmond, Va.) 
77.6 rnl (2% by vol) a sticker-spreader, such as "RHOP-
LEX B60A" Rohm & Haas Company, Philadelphia, 
Pa.) 3.24 liters (85.5% by vol) water 
A similar preparation is envisioned for the A21-MPV 
isolate. 
The amount of virus to be administered to the insect or the 
insect habitat is an amount effective to reduce insect infes-
tation as predetermined by routine testing. If the ultimate 
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response is insect mortality, an "insecticidally effective 
amount" is defined to be those qualities of virus which will 
result in a significant mortality rate of a test group, as 
compared to an untreated group. The insecticidally effective 
amount may vary with the species of pest, stage of larval 5 
development, nature of the substrate, the type of vehicle or 
carrier, the period of treatment and other factors. 
It is often advantageous to apply viral inoculants with a 
carrier. Suitable agronomically acceptable carriers are 
known in the art. Inert solids, such as cellulose or sugars, 10 
wetable powders, and aqueous surfactant mixtures are illus-
trative of suitable chemical carriers. Depending on many 
factors, the concentration of virus in the final composition 
may vary, but would include an insecticidally effective 
amount which may typically be between lxl08 to lxl011 15 
polyhedra per liter, but the preferred embodiment would be 
between lx1010 to lxlOll polyhedra per liter. 
Aerial application of Gypchek has been as follows: An 
airplane, such as 448 kW (600 hp) Grumman "AGCAT" . 
12 
airplane equipped with 8 atomizers, such as "AU 5000" 
atomizers manufactured by Micronair can be used for LdN-
MPV application. Delivery of formulated virus could be 
from 1.0xlOll to 5.0xlOll polyhedra in 7.5 liters per acre at 
an airspeed of 160 kmIh. (Podgwaite, et al., J. Economic 
Entomology, 85: 1136-1139). 
We claim: 
1. A method for protecting plants from insects against 
which LdMNPV is toxic, said method comprising applying 
to such insects or insect habitat an insecticidally effective 
amount of a virus designated ATCC VR2396 deposited at the 
American Type Culture Collection. 
2. A method according to claim 1, wherein said insects are 
gypsy moths. 
3. A method according to claim 2 wherein said insecti-
cidally effective amount is an amount sufficient to achieve 
the desired level of plant protection. 
* * * * * 
